BELVIN MARCIA (SVP, Chief Scientific Officer) received a stock award from CYTOMX THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/4/2026ACC: 0001610717-26-000041
Officer· SVP, Chief Scientific Officer
Since Feb 2026
+310K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
310K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+60K
Price / share
—
Trade value
—
% of position
22.0%
2/2/2026
272.25K→332.25K
Total
Net shares
+60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | A · Award | +60K | — | — | 22.0% | 272.25K | 332.25K |
| Total | +60K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
250K shares
Shares
+250K
Strike price
6.09
Held after
250K
Exercisable
—
2/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock250K shares | 2/2/2026 | A · Award | +250K | 6.09 | — | 250K |